博安生物（全称“山东博安生物技术股份有限公司”，股票代码：06955）于2026年3月5日发布截至2026年2月28日的股份变动月报表。报告显示，公司注册股本总额人民币622,333,694元（每股面值人民币1元），与上月保持一致，当月并无新增发行、购回或注销股份活动。
根据月报，公司于报告期内的普通股（H股）实缴发行数量仍为622,333,694股，库藏股份数为0股，合计发行股份总数保持不变。报告同时确认，公司当月无任何期权、权证、可换股票据或其他股本相关激励计划的变动。
公司在公告中表示，截至2月末，已发行股份的公众持股量符合香港联交所相关规定。公司强调已遵守香港联交所《上市规则》及适用法律法规，公告由董事姜华签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.